ICU Medical Q1 2020 Earnings Report
Key Takeaways
ICU Medical reported first quarter 2020 revenue of $328.6 million, a decrease compared to $330.9 million in the same period last year. GAAP net income was $16.8 million, or $0.78 per diluted share, compared to $31.0 million, or $1.44 per diluted share, for the first quarter of 2019. Adjusted diluted earnings per share were $1.81, compared to $2.58 for the first quarter of 2019. Adjusted EBITDA was $63.0 million, compared to $77.9 million for the first quarter of 2019.
First quarter revenue was $328.6 million, compared to $330.9 million in the same period last year.
GAAP gross profit was $121.4 million, compared to $135.3 million in the same period last year.
GAAP net income was $16.8 million, or $0.78 per diluted share, compared to $31.0 million, or $1.44 per diluted share, for the first quarter of 2019.
Adjusted diluted earnings per share were $1.81 as compared to $2.58 for the first quarter of 2019.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
The Company is revising adjusted EBITDA from a range of $240 million to $260 million to a range of $230 million to $250 million and adjusted earnings per share from a range of $6.50 to $7.20 to a range of $5.95 to $6.65.
Revenue & Expenses
Visualization of income flow from segment revenue to net income